|
[1]
|
Kawasaki, T. (1967) Acute Febrile Mucocutaneous Syndrome with Lymphoid Involvement with Specific Desquamation of the Fingers and Toes in Children. Arerugi, 16, 178-222.
|
|
[2]
|
Mccrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
|
|
[3]
|
Houska, N., Albertz, M. and Ing, R.J. (2025) Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement from the American Heart Association. Journal of Cardiothoracic and Vascular Anesthesia, 39, 1103-1105. https://doi.org/10.1053/j.jvca.2025.02.007
|
|
[4]
|
Day-Lewis, M., Son, M.B.F. and Lo, M.S. (2024) Kawasaki Disease: Contemporary Perspectives. The Lancet Child & Adolescent Health, 8, 781-792. https://doi.org/10.1016/s2352-4642(24)00169-x
|
|
[5]
|
Pilania, R.K., Tremoulet, A.H., Prinja, S., Dahdah, N. and Singh, S. (2025) Kawasaki Disease: The Most Common Cause of Acquired Heart Disease among Children Globally. Cardiology in the Young, 35, 441-443. https://doi.org/10.1017/s1047951125000459
|
|
[6]
|
Agarwal, S. and Agrawal, D.K. (2017) Kawasaki Disease: Etiopathogenesis and Novel Treatment Strategies. Expert Review of Clinical Immunology, 13, 247-258. https://doi.org/10.1080/1744666x.2017.1232165
|
|
[7]
|
Kang, C.R., Lee, J.S. and Choe, Y.J. (2025) Global Incidence of Kawasaki Disease: A Systematic Review. Cardiology in the Young, 35, 1028-1039.
|
|
[8]
|
Chaudhuri, M., Tomar, M. and Chattopadhyay, A. (2025) Imaging in Kawasaki Disease: The Past, Present, and Future. Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 9, 179-188. https://doi.org/10.4103/jiae.jiae_63_25
|
|
[9]
|
Hsu, W.F., Huang, Y.H., Tsai, F.J., et al. (2025) Epidemiological Trends and Healthcare Burden of Kawasaki Disease in Children under 5 Years in Taiwan Region. Scientific Reports, 15, Article No. 40622. https://doi.org/10.1038/s41598-025-24444-3
|
|
[10]
|
Park, Y.W. (2008) Epidemiology of Kawasaki Disease in Korea. Korean Journal of Pediatrics, 51, 452-456.
|
|
[11]
|
Shih, W.L., Huang, L.M., Wu, M.H., et al. (2024) Secular Trend of Kawasaki Disease and Its Correlation with Viral Activity in Taiwan Region: A Nationwide Population-Based Study. BMC Public Health, 24, Article No. 1591. https://doi.org/10.1186/s12889-024-19066-9
|
|
[12]
|
Goyal, T., Sharma, S., Pilania, R.K., Jawallia, K., Chawla, S., Sharma, M., et al. (2025) Genetic Landscape of Kawasaki Disease: An Update. Lymphatics, 3, Article 21. https://doi.org/10.3390/lymphatics3030021
|
|
[13]
|
Gorelik, M., Chung, S.A., Ardalan, K., Binstadt, B.A., Friedman, K., Hayward, K., et al. (2022) 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Care & Research, 74, 538-548. https://doi.org/10.1002/acr.24838
|
|
[14]
|
Shiono, Y., Takahata, M., Ino, Y., Tanimoto, T., Kakimoto, N., Suenaga, T., et al. (2024) Pathological Alterations of Coronary Arteries Late after Kawasaki Disease: An Optical Coherence Tomography Study. JACC: Advances, 3, Article 100937. https://doi.org/10.1016/j.jacadv.2024.100937
|
|
[15]
|
Mat Bah, M.N., Alias, E.Y., Sapian, M.H. and Abdullah, N. (2022) Delayed Diagnosis of Kawasaki Disease in Malaysia: Who Is at Risk and What Is the Outcome. Pediatrics International, 64, e15162. https://doi.org/10.1111/ped.15162
|
|
[16]
|
Liu, L., Chen, R., Wang, H., Yu, H., Ai, Z. and Zhang, X. (2025) Nutrition-Associated Biomarkers in Predicting Intravenous Immunoglobulin Resistance and Coronary Artery Lesions in Kawasaki Disease: A Systematic Review and Meta-Analysis. Food Science & Nutrition, 13, e4647. https://doi.org/10.1002/fsn3.4647
|
|
[17]
|
Jakubowski, H. and Witucki, Ł. (2025) Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular Disease. International Journal of Molecular Sciences, 26, Article 746. https://doi.org/10.3390/ijms26020746
|
|
[18]
|
郭永宏, 杨艳峰, 高放, 等. 同型半胱氨酸对人冠状动脉内皮细胞中组织蛋白酶V和炎症因子表达的影响机制[J]. 实用临床医药杂志, 2022, 26(3): 39-43.
|
|
[19]
|
孙欣娜, 于泊, 杨青, 等. 川崎病CK-MB、NT-proBNP、H-FABP和冠状动脉Z值的变化及其与冠脉病变的相关性研究[J]. 临床和实验医学杂志, 2022, 21(13): 1384-1387.
|
|
[20]
|
李明康. 非ST段抬高型急性冠脉综合征患者纤维蛋白原/白蛋白比值与冠脉病变程度及预后的相关性研究[D]: [硕士学位论文]. 南京: 东南大学, 2021.
|
|
[21]
|
黄玉娟, 李夙凌, 田园, 等. 中国儿童川崎病诊疗循证指南(2023年) [J]. 中国当代儿科杂志, 2023, 25(12): 1198-1210.
|
|
[22]
|
Kim, S.H. (2022) Diagnosis of Coronary Artery Abnormalities in Kawasaki Disease: Recent Guidelines and Z Score Systems. Clinical and Experimental Pediatrics, 65, 430-438. https://doi.org/10.3345/cep.2021.01459
|
|
[23]
|
Dallaire, F. and Dahdah, N. (2011) New Equations and a Critical Appraisal of Coronary Artery Z Scores in Healthy Children. Journal of the American Society of Echocardiography, 24, 60-74. https://doi.org/10.1016/j.echo.2010.10.004
|
|
[24]
|
Gerling, S., Hörl, M., Geis, T., Zant, R., Dechant, M., Melter, M., et al. (2022) Coronary Artery Z-Scores in Febrile Children with Suspected Kawasaki’s Disease—The Value of Serial Echocardiography. The Thoracic and Cardiovascular Surgeon, 70, e1-e6. https://doi.org/10.1055/s-0042-1747674
|
|
[25]
|
何方园, 何学华, 袁勇华, 等. 川崎病急性期血脂与年龄, 冠状动脉病变及严重程度的关系[J]. 临床儿科杂志, 2023, 41(6): 455-458.
|
|
[26]
|
Choueiter, N.F., Jone, P. and Harahsheh, A.S. (2025) Comparing the 2024 and 2017 Kawasaki Disease Statements from the American Heart Association. Pediatrics, 156, e2024069800. https://doi.org/10.1542/peds.2024-069800
|
|
[27]
|
Fukazawa, R., Kobayashi, J., Ayusawa, M., Hamada, H., Miura, M., Mitani, Y., et al. (2020) JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease. Circulation Journal, 84, 1348-1407. https://doi.org/10.1253/circj.cj-19-1094
|
|
[28]
|
Jone, P.N., Tremoulet, A., Choueiter, N., et al. (2024) Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement from the American Heart Association. Circulation, 150, e481-e500. https://doi.org/10.1161/cir.0000000000001295
|
|
[29]
|
de Graeff, N., Groot, N., Ozen, S., Eleftheriou, D., Avcin, T., Bader-Meunier, B., et al. (2019) European Consensus-Based Recommendations for the Diagnosis and Treatment of Kawasaki Disease—The SHARE Initiative. Rheumatology, 58, 672-682. https://doi.org/10.1093/rheumatology/key344
|
|
[30]
|
McCaddon, A. and Miller, J.W. (2023) Homocysteine—A Retrospective and Prospective Appraisal. Frontiers in Nutrition, 10, Article 1179807. https://doi.org/10.3389/fnut.2023.1179807
|
|
[31]
|
Suda, K., Iemura, M., Nishiono, H., Teramachi, Y., Koteda, Y., Kishimoto, S., et al. (2011) Long-Term Prognosis of Patients with Kawasaki Disease Complicated by Giant Coronary Aneurysms: A Single-Institution Experience. Circulation, 123, 1836-1842. https://doi.org/10.1161/circulationaha.110.978213
|
|
[32]
|
Echouffo‐Tcheugui, J.B., Zhang, S., Daya, N., McEvoy, J.W., Tang, O., Juraschek, S.P., et al. (2023) NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study. Journal of the American Heart Association, 12, e029110. https://doi.org/10.1161/jaha.122.029110
|
|
[33]
|
Li, D., Zhang, W.J., Feng, H.Q., et al. (2025) Elevated Levels of NT-proBNP, Interferon-γ and Tumor Necrosis Factor-α Are Associated with Coronary Artery Injury in Children with Severe Kawasaki Disease. American Journal of Translational Research, 17, 3683-3690. https://doi.org/10.62347/ajmb5384
|
|
[34]
|
孟欣, 白红艳, 李茜, 等. 纤维蛋白原/白蛋白比值血小板参数与冠状动脉病变程度相关性研究[J]. 河北医学, 2025, 31(8): 1364-1369.
|
|
[35]
|
杨安妮, 厉腊梅, 周桐, 等. 纤维蛋白原/白蛋白比值与早发冠心病的相关性研究[J]. 心血管病学进展, 2025, 46(9): 850-854.
|